Overview

Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to see if apricitabine or tipranavir affect the levels of each other in the blood (pharmacokinetic interaction) when they are dosed together.
Phase:
Phase 1
Details
Lead Sponsor:
Avexa
Treatments:
Tipranavir